Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden
· Delayed Price · Currency is SEK 26.95
+0.05 (0.19%)
Apr 28, 2026, 5:29 PM CET
Xspray Pharma AB Revenue
In the year 2025, Xspray Pharma AB had annual revenue of 2.47M SEK. Xspray Pharma AB had revenue of 2.47M in the quarter ending December 31, 2025.
Revenue
2.47M
Revenue Growth
n/a
P/S Ratio
456.19
Revenue / Employee
94.85K
Employees
26
Market Cap
1.12B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medivir AB | 8.51M |
| Cantargia AB | 316.70M |
| Genovis AB (publ.) | 129.65M |
| BioInvent International AB | 226.50M |
| Infant Bacterial Therapeutics AB | -1.00K |
| FluoGuide | 318.79K |
| Saniona AB | 434.40M |
| Flerie AB | 1.80M |
Xspray Pharma AB News
- 2 years ago - Xspray Pharma AB Transcript: Status Update - Transcripts
- 5 years ago - Xspray Pharma AB Transcript: Pareto Securities’ Annual Healthcare Conference 2021 - Transcripts